Anuh Pharma inaugurates new manufacturing facility F-10/1 and starts production
Anuh Pharma · Pharmaceuticals & Biotechnology
Key highlights
- New manufacturing facility at F-10/1, M.I.D.C., Tarapur, Boisar, Maharashtra inaugurated on 15th November 2026
- Facility to be fully operational by December 2026, adding 525 MT/Annum to production capacity
- Total production capacity increased from approx. 2,400 MT/Annum to 2,925 MT/Annum with 56 KL added reactor capacity
Original filing
Announcement Under Regulation 30 (LODR) - Inauguration Of Manufacturing Facility F-10/1 And Commencement Of Commercial Production Of The Company.
Read the filing on BSE (PDF) →Companies guiding to strong growth
Ranked by management's own guidance on revenue and margins — not by us.
Aerospace & Defense
Sign up free to see all 6 →
See full rankingsRank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Other capex / expansion filings this fortnight
- Capex / expansionRaksan TransformersRaksan Transformers reports H1FY27 results with ₹121.1 crore revenue and ₹427 crore order book
- Capex / expansionMadhya Bharat Agro ProductsMadhya Bharat Agro Products Ltd reports Q2 & H1 FY27 financial results with strong growth
- Capex / expansionWaaree EnergiesWaaree Energies' subsidiary commissions new 5.15 GWh battery pack manufacturing line
- Capex / expansionBeardsellBeardsell Limited publishes unaudited Q2 & H1 FY27 financial results and approves factory expansion
- Capex / expansionBeardsellBeardsell Limited releases unaudited Q2 FY2026 financials and approves expansion
- Capex / expansionJamna Auto IndustriesJamna Auto Industries Ltd. to set up new leaf spring plant at Malanpur in 2027
Potential multibaggers · Q2 FY27
Potential multibaggers in Pharmaceuticals & Biotechnology
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Summary written by Arthneeti from the company's filing with the stock exchange; check the original filing for full details. Arthneeti is a research and analytics platform, not a SEBI-registered investment adviser, and nothing here is a recommendation to buy or sell.